本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

23.54
+1.536.95%
盤前23.750.2100+0.89%07:49 EDT
成交量:247.76萬
成交額:5,692.45萬
市值:14.00億
市盈率:-9.80
高:23.64
開:21.41
低:21.27
收:22.01
52周最高:40.65
52周最低:11.82
股本:5,948.52萬
流通股本:3,521.10萬
量比:1.21
換手率:7.04%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
淨資產收益率:-45.31%
總資產收益率:-28.46%
市淨率:3.96
市盈率(LYR):-11.70

資料載入中...

2026/09/09

重要事件披露

Form 8-K - Current report
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors